Skip to the page

Data / Form D filings / Nanopath Inc

Nanopath Inc: Form D filings

Nanopath Inc, a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on February 6, 2025, reports $5.3 million sold of a $6 million offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
750 MAIN STREET, Cambridge, MA, 02139
Phone
(617) 249-4542
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1940981

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 6, 2025New notice$6,000,000$5,341,000$659,0005Jan 24, 2025sec.gov
Aug 9, 2022New notice$10,000,000$10,000,00010Jun 14, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alison BurklundExecutive Officer, Director
Aaron SandoskiDirector
Amogha TadimetyExecutive Officer, Director
Jeff CroweDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Feb 3, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Nanopath Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.